Background: Chronic kidney disease (CKD) is the most common renal disease. Renal interstitial fibrosis (RIF) is an important marker of the progression of chronic kidney disease. Epithelial-interstitial transformation (EMT) and the release of inflammatory factors are the core mechanisms underlying RIF.
Results: A type of orally administered nanoconjugate composed of curcumin and sericin was successfully synthesized. Following unilateral ureteral obstruction (UUO) in mice, oral gavage of nanoconjugates could significantly downregulate cytokines and proteins that participate in fibrosis in vivo.
Conclusion: In general, sericin-curcumin nanoconjugate dosing via oral administration is an easy and effective therapeutic strategy for suppressing or even reversing the progression of renal interstitial fibrosis.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.